Citation: | Jia Baoxiang, Zhang Dong, Wu Junjie, et al. Study on the relationship between panel reactive antibody and long-term prognosis of transplant renal function[J]. ORGAN TRANSPLANTATION, 2014, 5(6): 360-363. doi: 10.3969/j.issn.1674-7445.2014.06.007 |
[1] |
李留洋, 陈剑荣, 钱俊, 等. 肾移植术后急性体液性排斥反应的监测及其临床意义[J]. 中华器官移植杂志, 2012, 33(3):141-144.
Li LY, Chen JR, Qian J, et al. Significance of monitoring acute humoral rejection after renal transplantation[J].Chin J Organ Transplant, 2012, 33(3): 141-144.
|
[2] |
Yamanaga S, Watarai Y, Takeda A, et al. Acute antibody-mediated rejection possibly due to anti-human leukocyte antigen DQB1 antibodies after renal transplantation :case report[J]. Transplant Proc, 2014, 46(2):640-643. doi: 10.1016/j.transproceed.2013.11.012
|
[3] |
Huh KH, Kim MS, Kim HJ, et al.Renal transplantation in sensitized recipients with positive luminex and negative CDC (complement-dependent cytotoxicity) crossmatches[J]. Transpl Int, 2012, 25(11):1131-1137. doi: 10.1111/j.1432-2277.2012.01543.x
|
[4] |
徐恩五, 于立新, 曾伟生, 等. 肾移植术后早期移植肾失功的危险因素分析[J]. 器官移植, 2010, 1(1):295-299. http://www.cnki.com.cn/Article/CJFDTOTAL-QGYZ201005011.htm
Xu EW, Yu LX, Zeng WS, et al.Risk factors of early non-functioning renal allograft after renal transplantation[J]. Organ Transplant, 2010, 1(1):295-299. http://www.cnki.com.cn/Article/CJFDTOTAL-QGYZ201005011.htm
|
[5] |
贾保祥, 武俊杰, 孙利宁, 等. 2429例尿毒症患者致敏因素的分析[J].中华器官移植杂志, 2010, 31(7):429-432.
Jia BX, Wu JJ, Sun LN, et al. Analysis of sensitized factors in 2429 urinemia patients[J]. Chin J Organ Transplant, 2010, 31(7):429-432.
|
[6] |
肖露露, 于立新, 郑克立. 等候肾移植者群体反应性抗体的变化及HLA致敏途径对其的影响[J]. 中华器官移植杂志, 2012, 33(3):133-136.
Xiao LL, Yu LX, Zheng KL. Changes of PRA and effects of HLA sensitized paths in patients waiting for renal transplantation[J]. Chin J Organ Transplant, 2012, 33(3):133-136.
|
[7] |
Hung SY, Lin TM, Chang MY, et al. Risk factors of sensitization to human leukocyte antigen in end-stage renal disease patients[J]. Hum Immunol, 2014, 75(6):531-535. doi: 10.1016/j.humimm.2014.02.024
|
[8] |
Kurtulmuş Y, Ayna TK, Soyöz M, et al. Comparision of anti-HLA antibodies of kidney transplant candidates with chronic renal failure by two different methods: Flow-PRA and Luminex PRA[J].Transplant Proc, 2013, 45(3):875-877. doi: 10.1016/j.transproceed.2013.02.074
|
[9] |
陈栋, 张伟杰, 陈刚, 等. 肾移植前对致敏患者干预治疗的方案及疗效分析[J].中华器官移植杂志, 2013, 34(4):202-205.
Chen D, Zhang WJ, Chen G, et al. Therapeutic options and efficacy analysis of sensitized renal transplant recipients[J]. Chin J Organ Transplant, 2013, 34(4):202-205.
|
[10] |
刘天来, 刘永光, 赵明, 等. 血浆置换联合利妥昔单抗治疗肾移植术后抗体介导的排斥反应1例报告并文献复习[J]. 器官移植, 2012, 3(2):83-86. http://www.cnki.com.cn/Article/CJFDTOTAL-QGYZ201202007.htm
Liu TL, Liu YG, Zhao M, et al. Plasmapheresis combination with rituximab in treatment of antibody mediated rejection after renal transplantation: a case report and literature review[J]. Organ Transplant, 2012, 3(2):83-86. http://www.cnki.com.cn/Article/CJFDTOTAL-QGYZ201202007.htm
|
[11] |
Brokhof MM, Sollinger HW, Hager DR, et al. Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipients[J]. Transplantation, 2014, 97(6):612-617. doi: 10.1097/TP.0000000000000031
|
[12] |
Ejaz NS, Shields AR, Alloway RR, et al. Randomized controlled pilot study of B cell-targeted induction therapy in HLA sensitized kidney transplant recipients[J]. Am J Transplant, 2013, 13(12):3142-3154. doi: 10.1111/ajt.12493
|
[13] |
Shang W, Dong L, Feng G, et al. Panel-reactive antibody levels and renal transplantation rates in sensitized patients after desensitization and human leucocyte antigen amino acid residue matching[J]. J lnt Med Res, 2013, 41(4):1333-1341. http://cn.bing.com/academic/profile?id=2146501570&encoded=0&v=paper_preview&mkt=zh-cn
|
[14] |
Jin MK, Cho JH, Kwon O, et al. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience[J]. Transplant Proc, 2012, 44(1):200-203. doi: 10.1016/j.transproceed.2011.11.040
|
[15] |
Gubensek J, Buturovic-Ponikvar J, Kandus A, et al. Plasma exchange and intravenous immunoglobulin in the treatment of antibody-mediated rejection after kidney transplantation: a single-center historic cohort study[J]. Transplant Proc, 2013, 46(4):1524-1527. http://cn.bing.com/academic/profile?id=2072653061&encoded=0&v=paper_preview&mkt=zh-cn
|
[16] |
Shah T, Vo D, Corrales-Tellez E, et al. Effects of mycophenolic acid on highly sensitized patients awaiting kidney transplant[J]. Transpl Immunol, 2013, 18(1):32-37. http://cn.bing.com/academic/profile?id=2085667181&encoded=0&v=paper_preview&mkt=zh-cn
|
[17] |
Dunn TB, Noreen H, Gillingham K, et al. Revisiting traditional risk factors for rejection and graft loss after kidney transplantation[J]. Am J Transplant, 2011, 11(10):2132-2143. doi: 10.1111/ajt.2011.11.issue-10
|